Exendin 9 39 ex 9 39

Manufactured by Merck Group

Sourced in United States

Exendin(9-39) (Ex(9-39)) is a synthetic peptide that corresponds to the 9-39 amino acid sequence of the exendin-4 peptide. It functions as a selective antagonist of the glucagon-like peptide-1 (GLP-1) receptor.

Automatically generated - may contain errors

Lab products found in correlation

Lithium chloride (licl), by Fujifilm (1 mentions) Porcine insulin, by Merck Group (1 mentions) D glucose, by Fujifilm (1 mentions) Oxytocin, by Peptide Institute (1 mentions) D mannitol, by Fujifilm (1 mentions) Sitagliptin phosphate, by Merck Group (1 mentions) Dpp 4, by Merck Group (1 mentions)

Spelling variants of this product

Exendin 9-39 (21 citations) Exendin-9 (4 citations)

2 protocols using exendin 9 39 ex 9 39

Rare Sugar D-Allulose Bioactivity Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols

d-Allulose was provided by Kagawa University Rare Sugar Research Center and Matsutani Chemical Industry Co. Ltd. The purity of d-allulose was higher than 98%. d-glucose, d-mannitol, and lithium chloride were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). GLP-1(7-36 amide) and oxytocin were from Peptide Institute (Osaka. Japan). Porcine insulin was from Sigma (MO), and exendin(9-39) (Ex(9-39)) was from Abgent (CA).

Iwasaki Y., Sendo M., Dezaki K., Hira T., Sato T., Nakata M., Goswami C., Aoki R., Arai T., Kumari P., Hayakawa M., Masuda C., Okada T., Hara H., Drucker D.J., Yamada Y., Tokuda M, & Yada T. (2018). GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose. Nature Communications, 9, 113.

+ Open protocol

+ Expand

Exendin 9-39 and Sitagliptin Comparative Study

Check if the same lab product or an alternative is used in the 5 most similar protocols

TQ (purity >98%) and exendin 9–39 (Ex 9–39) were obtained from Sigma Aldrich Chemical Co. (St. Louis, MO, USA). Sitagliptin phosphate (Merck, Cramlington, Northumberland, UK), which inhibits dipeptidyl peptidase-4 (DPP-4) (Sigma Aldrich), was dissolved in normal saline.

Lee S.P., Kuo F.Y., Cheng J.T, & Wu M.C. (2019). GLP-1 mediates the modulating effect of thymoquinone on feeding behaviors in diabetic rats. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 12, 873-881.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!